Hepatic Encephalopathy: An Update of Pathophysiologic Mechanisms (44433A)
暂无分享,去创建一个
[1] P. Desjardins,et al. Chronic exposure of rat primary astrocyte cultures to manganese results in increased binding sites for the ‘peripheral-type’ benzodiazepine receptor ligand 3H-PK 11195 , 1999, Neuroscience Letters.
[2] P. Desjardins,et al. Increased expression of glyceraldehyde-3-phosphate dehydrogenase in cultured astrocytes following exposure to manganese , 1999, Neurochemistry International.
[3] M. Norenberg,et al. Effect of benzodiazepines and neurosteroids on ammonia‐induced swelling in cultured astrocytes , 1998, Journal of neuroscience research.
[4] M. Bugge,et al. Regional brain serotonin receptor changes in portacaval shunted rats. , 1998, Acta physiologica Scandinavica.
[5] R. Butterworth,et al. Evidence for altered central noradrenergic function in experimental acute liver failure in the rat , 1998, Hepatology.
[6] D. Krieger,et al. Manganese Augments Nitric Oxide Synthesis in Murine Astrocytes: A New Pathogenetic Mechanism in Manganism? , 1998, Experimental Neurology.
[7] M. Norenberg,et al. The glial glutamate transporter in hyperammonemia and hepatic encephalopathy: Relation to energy metabolism and glutamatergic neurotransmission , 1997, Glia.
[8] R. Butterworth,et al. Increased neuronal nitric oxide synthase expression in brain following portacaval anastomosis , 1997, Brain Research.
[9] R. Butterworth,et al. Decreased glutamate transporter (GLT-1) expression in frontal cortex of rats with acute liver failure , 1997, Neuroscience Letters.
[10] G. Kircheis,et al. Therapeutic efficacy of L‐ornithine‐L‐aspartate infusions in patients with cirrhosis and hepatic encephalopathy: Results of a placebo‐controlled, double‐blind study , 1997, Hepatology.
[11] A. Katchman,et al. Nitric oxide modulates synaptic glutamate release during anoxia , 1997, Neuroscience Letters.
[12] R. Butterworth. Hepatic encephalopathy and brain edema in acute hepatic failure: Does glutamate play a role? , 1997, Hepatology.
[13] R. Chamuleau,et al. Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia‐induced encephalopathy and acute hepatic encephalopathy in rats , 1997, Hepatology.
[14] R. Butterworth,et al. Increased blood manganese in cirrhotic patients: Relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms , 1996, Hepatology.
[15] R. Butterworth,et al. Brain Extracellular Quinolinic Acid in Chronic Experimental Hepatic Encephalopathy as Assessed by In Vivo Microdialysis: Acute Effects of L-Tryptophan , 1996, Neuropsychopharmacology.
[16] R. Butterworth,et al. Neuroactive amino acids and glutamate (NMDA) receptors in frontal cortex of rats with experimental acute liver failure , 1996, Hepatology.
[17] C. Yurdaydın,et al. Modulation of hepatic encephalopathy in rats with thioacetamide-induced acute liver failure by serotonin antagonists. , 1996, European journal of gastroenterology & hepatology.
[18] S. Mckinzie,et al. Releases of Norepinephrine and Dopamine in Ventriculocisternal Perfusions in Hepatectomized and Laparotomized Rats , 1996, Journal of neurochemistry.
[19] R. Wiesner,et al. Concentrations of 3,4‐Dihydroxyphenylalanine and Catecholamines and Metabolites in Brain in an Anhepatic Model of Hepatic Encephalopathy , 1995, Journal of neurochemistry.
[20] R. Butterworth,et al. Increased Nitric Oxide Synthase Activities and l‐[3H]Arginine Uptake in Brain Following Portacaval Anastomosis , 1995, Journal of neurochemistry.
[21] D. Krieger,et al. Manganese and chronic hepatic encephalopathy , 1995, The Lancet.
[22] R. Butterworth,et al. Increased manganese concentrations in pallidum of cirrhotic patients , 1995, The Lancet.
[23] C. Martínez,et al. Manganese intoxication and chronic liver failure , 1994, Annals of Neurology.
[24] R. Hawkins,et al. Metabolic Abnormalities and Grade of Encephalopathy in Acute Hepatic Failure , 1994, Journal of neurochemistry.
[25] A. Levey,et al. Localization of neuronal and glial glutamate transporters , 1994, Neuron.
[26] M. Norenberg,et al. Ammonia-induced upregulation of peripheral-type benzodiazepine receptors in cultured astrocytes labeled with [3H]PK 11195 , 1994, Neuroscience Letters.
[27] A. Mamourian,et al. Dystonia, hyperintense basal ganglia, and high whole blood manganese levels in Alagille's syndrome. , 1994, Gastroenterology.
[28] Á. Párducz,et al. Gonadal hormone regulation of glial fibrillary acidic protein immunoreactivity and glial ultrastructure in the rat neuroendocrine hypothalamus , 1994, Glia.
[29] R. Butterworth,et al. Increased Densities of Binding Sites for the Peripheral-Type Benzodiazepine Receptor Ligand [3H]PK 11195 in Congenital Ornithine Transcarbamylase-Deficient Sparse Fur Mouse , 1993, Pediatric Research.
[30] E. Soriano,et al. Gonadal hormones down-regulate reactive gliosis and astrocyte proliferation after a penetrating brain injury , 1993, Brain Research.
[31] A. Lockwood,et al. Positron‐emission tomographic localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy , 1993, Hepatology.
[32] C. Angle,et al. Manganese encephalopathy: utility of early magnetic resonance imaging. , 1993, British journal of industrial medicine.
[33] V. Papadopoulos. Peripheral-type benzodiazepine/diazepam binding inhibitor receptor: biological role in steroidogenic cell function. , 1993, Endocrine reviews.
[34] J. Kulisevsky,et al. Pallidal hyperintensity on magnetic resonance imaging in cirrhotic patients: Clinical correlations , 1992, Hepatology.
[35] R. Butterworth,et al. Effect of ammonium ions on synaptic transmission in the mammalian central nervous system , 1992, Progress in Neurobiology.
[36] E. Hamel,et al. Increased densities of binding sites for the ‘peripheral-type’ benzodiazepine receptor ligand [3H]PK 11195 in rat brain following portacaval anastomosis , 1992, Brain Research.
[37] R. Hughes,et al. Electron microscopic study of brain capillaries in cerebral edema from fulminant hepatic failure , 1992, Hepatology.
[38] P. Tomlin,et al. Fatal liver failure following generalized tonic-clonic seizures , 1992, Seizure.
[39] M. Majewska,et al. Neurosteroids: Endogenous bimodal modulators of the GABAA receptor mechanism of action and physiological significance , 1992, Progress in Neurobiology.
[40] Jon Driver,et al. The neurobiology of selective attention , 1992, Current Opinion in Neurobiology.
[41] E. Baulieu,et al. Demonstration of steroid hormone receptors and steroid action in primary cultures of rat glial cells , 1992, The Journal of Steroid Biochemistry and Molecular Biology.
[42] Michael Aschner,et al. Manganese Uptake and Efflux in Cultured Rat Astrocytes , 1992, Journal of neurochemistry.
[43] G. Marcaida,et al. Acute ammonia toxicity is mediated by the NMDA type of glutamate receptors , 1992, FEBS letters.
[44] S. Mirowitz,et al. Hyperintense basal ganglia on T1-weighted MR images in patients receiving parenteral nutrition. , 1991, Radiology.
[45] R. Koehler,et al. Inhibition of brain glutamine accumulation prevents cerebral edema in hyperammonemic rats. , 1991, The American journal of physiology.
[46] P. Dodd,et al. Alterations in Cortical [3H]Kainate and α‐[3H]Amino‐3‐Hydroxy‐5‐Methyl‐4‐Isoxazolepropionic Acid Binding in a Spontaneous Canine Model of Chronic Hepatic Encephalopathy , 1991, Journal of neurochemistry.
[47] Klaus P. Ebmeier,et al. Regional cerebral blood flow and cognitive function in patients with chronic liver disease , 1991, The Lancet.
[48] S. Hori,et al. Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images. , 1991, Radiology.
[49] R. Butterworth,et al. Effect of Portacaval Anastomosis on Electrically Stimulated Release of Glutamate from Rat Hippocampal Slices , 1991, Journal of neurochemistry.
[50] S. Moncada,et al. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? , 1991, The Lancet.
[51] W H Wong,et al. Altered Cerebral Blood Flow and Glucose Metabolism in Patients with Liver Disease and Minimal Encephalopathy , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[52] A. Lockwood,et al. Cerebral Ammonia Metabolism in Patients with Severe Liver Disease and Minimal Hepatic Encephalopathy , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[53] R. Butterworth,et al. Brain Tryptophan Hydroxylation in the Portacaval Shunted Rat: A Hypothesis for the Regulation of Serotonin Turnover In Vivo , 1991, Journal of neurochemistry.
[54] P. Skolnick,et al. The pathogenesis and treatment of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptor ligands. , 1991, Pharmacological reviews.
[55] R. Butterworth,et al. Neurochemical and electrophysiological studies on the inhibitory effect of ammonium ions on synaptic transmission in slices of rat hippocampus: Evidence for a postsynaptic action , 1990, Neuroscience.
[56] A. Guidotti,et al. Endogenous Benzodiazepine Receptor Ligands in Human and Animal Hepatic Encephalopathy , 1990, Journal of neurochemistry.
[57] C. Yurdaydın,et al. Increased serotoninergic and noradrenergic activity in hepatic encephalopathy in rats with thioacetamide—induced acute liver failure , 1990, Hepatology.
[58] S. H. Zaman. Endogenous steroids and pathogenesis of hepatic encephalopathy , 1990, The Lancet.
[59] C. Cotman,et al. Selective Loss of N‐Methyl‐d‐Aspartate‐Sensitive l‐[3H]Glutamate Binding Sites in Rat Brain Following Portacaval Anastomosis , 1990, Journal of neurochemistry.
[60] R. Butterworth,et al. Effect of Ammonia on Brain Serotonin Metabolism in Relation to Function in the Portacaval Shunted Rat , 1990, Journal of neurochemistry.
[61] R. Butterworth,et al. Increased densities of peripheral‐type benzodiazepine receptors in brain autopsy samples from cirrhotic patients with hepatic encephalopathy , 1990, Hepatology.
[62] J. Albrecht,et al. Activation of arginine metabolism to glutamate in rat brain synaptosomes in thioacetamide‐induced hepatic encephalopathy: An adaptative response? , 1990, Journal of neuroscience research.
[63] Bernard Weiss,et al. Visualizing manganese in the primate basal ganglia with magnetic resonance imaging , 1989, Experimental Neurology.
[64] J. Lai,et al. Effect of orally administered L‐carnitine on blood ammonia and L‐carnitine concentrations in portacaval‐shunted rats , 1989, Hepatology.
[65] M. Santi,et al. Differences in the negative allosteric modulation of gamma-aminobutyric acid receptors elicited by 4'-chlorodiazepam and by a beta-carboline-3-carboxylate ester: a study with natural and reconstituted receptors. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[66] M. Norenberg,et al. Effect of ammonium chloride on the astrocyte benzodiazepine receptor , 1989, Brain Research.
[67] R. Groszmann,et al. Long‐term hemodynamic effects of ketanserin, a 5‐hydroxytryptamine blocker, in portal hypertensive patients , 1989, Hepatology.
[68] M. Losowsky,et al. Plasma methionine enkephalin concentration and prognosis in primary biliary cirrhosis. , 1988, BMJ.
[69] B. McEwen,et al. Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action. , 1988, The Journal of pharmacology and experimental therapeutics.
[70] S. Vicini,et al. Neurosteroid pregnenolone sulfate antagonizes electrophysiological responses to GABA in neurons , 1988, Neuroscience Letters.
[71] R. Butterworth,et al. Hepatic encephalopathy in cirrhotic and portacaval shunted dogs: Lack of changes in brain GABA uptake, brain GABA levels, brain glutamic acid decarboxylase activity and brain postsynaptic GABA receptors , 1988, Hepatology.
[72] M. Norenberg. Hepatic encephalopathy studies with astrocyte cultures , 1988 .
[73] D. Ganger,et al. Electron microscopic evaluation of brain edema in rabbits with galactosamine‐induced fulminant hepatic failure: Ultrastructure and integrity of the blood‐brain barrier , 1987, Hepatology.
[74] R. D. Schwartz,et al. Pregnenolone-sulfate: an endogenous antagonist of the γ-aminobutyric acid receptor complex in brain? , 1987, Brain Research.
[75] R. Butterworth,et al. Ammonia: key factor in the pathogenesis of hepatic encephalopathy. , 1987, Neurochemical pathology.
[76] C. Mendenhall,et al. A new therapy for portal systemic encephalopathy. , 1986, The American journal of gastroenterology.
[77] M. E. Lewis,et al. Anatomy of the CNS opioid systems , 1985, Trends in Neurosciences.
[78] J. Bircher,et al. Increased ethanol consumption and blood ethanol levels in rats with portacaval shunts. , 1985, The American journal of physiology.
[79] E. Jones,et al. Visual evoked potentials in a rabbit model of hepatic encephalopathy. I. Sequential changes and comparisons with drug-induced comas. , 1984, Gastroenterology.
[80] S. Grisolía,et al. Protective effect of L‐carnitine on hyperammonemia , 1984, FEBS letters.
[81] P. Munson,et al. Gamma-aminobutyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure. , 1983, The Journal of laboratory and clinical medicine.
[82] F. Plum,et al. Acute Hyperammonemia in the Young Primate: Physiologic and Neuropathologic Correlates , 1983, Pediatric Research.
[83] N. Cruz,et al. Local Cerebral Glucose Metabolism in Rats with Chronic Portacaval Shunts , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[84] C. Cortesini,et al. The Release and Neosynthesis of Glutamic Acid Are Increased in Experimental Models of Hepatic Encephalopathy , 1983, Journal of neurochemistry.
[85] P. Mantegazza,et al. Brain β-endorphin concentrations in experimental chronic liver disease , 1982, Brain Research.
[86] C. Sewell,et al. Deficiency of carnitine in cachectic cirrhotic patients. , 1977, The Journal of clinical investigation.
[87] F. Plum,et al. Effect of acute ammonia intoxication on cerebral metabolism in rats with portacaval shunts. , 1977, The Journal of clinical investigation.
[88] R. Williams,et al. Plasma and Brain Amino Acids in Fulminant Hepatic Failure and their Relationship to Hepatic Encephalopathy , 1976, European journal of clinical investigation.
[89] J. B. Martin,et al. Relationships between tryptophan in serum and CSF, and 5-hydroxyindoleacetic acid in CSF of man: effect of cirrhosis of liver and probenecid administration. , 1975, Journal of neurology, neurosurgery, and psychiatry.
[90] J. Versieck,et al. Manganese, copper, and zinc concentrations in serum and packed blood cells during acute hepatitis, chronic hepatitis, and posthepatitic cirrhosis. , 1974, Clinical chemistry.
[91] S. Miller,et al. Role of liver in regulating distribution and excretion of manganese. , 1966, The American journal of physiology.
[92] F. Ebner,et al. EXPERIMENTAL MANGANESE ENCEPHALOPATHY IN MONKEYS: A Preliminary Report , 1963, Journal of neuropathology and experimental neurology.
[93] J. Laidlaw,et al. Morphine tolerance in hepatic cirrhosis. , 1961, Gastroenterology.
[94] C. S. Davidson,et al. Reversible toxic manifestations in patients with cirrhosis of the liver given cation-exchange resins. , 1952, The New England journal of medicine.
[95] M. Norenberg,et al. The peripheral benzodiazepine receptor and neurosteroids in hepatic encephalopathy. , 1997, Advances in experimental medicine and biology.
[96] V. Felipo,et al. Superoxide production and antioxidant enzymes in ammonia intoxication in rats. , 1997, Free radical research.
[97] A. Guidotti,et al. Diazepam binding inhibitor (DBI): a peptide with multiple biological actions. , 1991, Life sciences.
[98] R. Koehler,et al. Elevated Brain Water During Urease-Induced Hyperammonemia in Dogs , 1989 .
[99] M. Baraldi,et al. BETA-ENDORPHIN AND OPIATE RECEPTOR CHANGES IN ACUTE AND CHRONIC MODELS OF HEPATIC ENCEPHALOPATHY , 1989 .
[100] P. Traber,et al. Brain Edema in Experimental Fulminant Hepatic Failure , 1989 .
[101] W. Raabe. Neurophysiology of Ammonia Intoxication , 1989 .
[102] E. Roberts,et al. Dehydroepiandrosterone and its sulfated derivative reduce neuronal death and enhance astrocytic differentiation in brain cell cultures , 1987, Journal of neuroscience research.
[103] K. Kusuda,et al. Cerebrospinal fluid lactate in patients with hepatic encephalopathy. , 1987, European neurology.
[104] P. Munson,et al. Changes in Glutamate Receptors on Synaptic Membranes Associated with Hepatic Encephalopathy or Hyperammonemia in the Rabbit , 1984, Hepatology.
[105] M. Norenberg. The astrocyte in liver disease. , 1971, Lancet.